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ABSTRACT
Introduction In its recent World Report on Vision, 
the WHO called for an updated approach to monitor 
eye health as part of universal health coverage (UHC). 
This project sought to develop a consensus among eye 
health experts from all world regions to produce a menu 
of indicators for countries to monitor eye health within 
UHC.
Methods We reviewed the literature to create a long- 
list of indicators aligned to the conceptual framework for 
monitoring outlined in WHO’s World Report on Vision. 
We recruited a panel of 72 global eye health experts 
(40% women) to participate in a two- round, online 
prioritisation exercise. Two- hundred indicators were 
presented in Round 1 and participants prioritised each 
on a 4- point Likert scale. The highest- ranked 95 were 
presented in Round 2 and were (1) scored against four 
criteria (feasible, actionable, reliable and internationally 
comparable) and (2) ranked according to their suitability 
as a ’core’ indicator for collection by all countries. The 
top 30 indicators ranked by these two parameters were 
then used as the basis for the steering group to develop 
a final menu.
Results The menu consists of 22 indicators, including 7 
core indicators, that represent important concepts in eye 
health for 2020 and beyond, and are considered feasible, 
actionable, reliable and internationally comparable.
Conclusion We believe this list can inform the 
development of new national eye health monitoring 
frameworks, monitor progress on key challenges to eye 
health and be considered in broader UHC monitoring 
indices at national and international levels.
INTRODUCTION
In its first World Report on Vision released in 2019, 
WHO included the strengthening of health infor-
mation systems (HIS) among its five global priority 
areas for action.1 This recognises the critical role 
of HIS to provide information—from population- 
based surveys, facility- based sources and adminis-
trative data—to guide health policy, management 
and clinical care. Among WHO’s recommended 
actions were to strengthen national capacity to 
collect, analyse and use data on eye health, and 
the creation of a global indicator menu for eye 
health from which countries can select relevant 
indicators.1
The priority placed on HIS in the World Report 
on Vision also reflects the limited progress made 
to date. Several lists of indicators have accompa-
nied global eye health initiatives over the past two 
decades.2–5 Inconsistent reporting against these 
lists over time may be due to under- investment 
in district- level HIS capacity in low- income and 
middle- income settings, the vertical nature of 
many eye health systems, variable levels of engage-
ment from national eye care planners and limited 
public–private sector cooperation.6–8 In addition, a 
lack of policy imperative may be due to an absence 
of eye health indicators in WHO’s global health 
monitoring frameworks to date.9 10
Based on these and other challenges, in its 
Universal Eye Health: A Global Action Plan 2014–
20194 (hereafter ‘GAP’) in 2013, WHO emphasised 
the need for eye care to be integrated into broader 
health planning. The World Report on Vision went 
further to state that eye health should be considered 
an essential component of universal health coverage 
(UHC).1 Monitoring global eye health as part of 
UHC and the United Nations’ Sustainable Devel-
opment Goals11 requires an updated menu of indi-
cators aligned with the UHC dimensions of access, 
quality, financial risk protection and equity.
Here we report a collaborative prioritisation 
process to generate a menu of indicators that may 
be used by governments to monitor and improve 
eye health and eye health services at the national 
level, and to support progress towards achieving 
UHC. This work was undertaken as part of the 




A two- round, prioritisation exercise was under-
taken between February and April 2020 using an 
online survey platform ( www. qualtrics. com). All 
panellists’ responses were de- identified throughout, 
however, individuals were provided the option to 
join a study authorship group.
Participants
A project steering group (the co- authors) was 
convened to guide the development of the initial 
long- list of indicators, nominate panellists from 
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indicator scoring and develop the final menu. We aimed to 
recruit panellists from all Global Burden of Disease (GBD) Super 
Regions,13 with equal numbers of men and women per region. 
In total 74 out of 84 invited panellists participated in Round 1 
and 72 went on to complete Round 2 (response rate after Round 
2, 85.7%). Men were 59.7% of the Round 2 panel, similar 
to the proportion among all invitees. Eleven members of the 
steering group participated, five from a ‘global’ (non- Regional) 
perspective. Thirty- nine countries and all GBD Super Regions 
had participants in both rounds and 85% of the Round 2 panel 
represented low- income or middle- income countries (table 1). 
Round 2 panellists most frequently reported their roles within 
eye health as ‘management/leadership’ (25.0%), ‘epidemiology’ 
(12.5%), ‘clinician/practitioner’ (12.5%), ‘eye health services 
research’ (9.7%), ‘government/Ministry of Health’, ‘clinical 
research’ and ‘international institution’ (all 6.9%).
Initial indicator selection
A long- list of indicators was compiled with reference to previ-
ously proposed eye health indicators and existing international 
health and health systems indicator lists, adapted for relevance to 
the eye health sector where necessary. This long- list was mapped 
to the domains of measurement of HIS used in the World Report 
on Vision (adapted from the 2012 WHO Framework and stan-
dards for country health information systems) (figure 1). When 
panellists were invited to participate, they were asked to suggest 
additional indicators for consideration. The steering group 
reviewed all indicators identified, only excluding obvious dupli-
cates in order to avoid biassing the pool of potential indicators. 
At the end of this process 200 indicators were included (online 
supplemental appendix 1).
The prioritisation exercise: round 1
Panellists scored the indicators based on perceived priority in 
their context. Priority was scored from 1 to 4 on a Likert scale, 
with 1 representing the lowest priority ('no need to collect') 
and 4 the highest priority ('essential to collect') (online supple-
mental appendices 2 and 3). A fifth option, (0 = ‘redundant’) 
was included to allow for the fact that the long- list had not 
been heavily edited and some overlap of indicator concepts was 
possible. A priority score for each indicator was calculated by 
summing the products of two dimensions: the Likert scale score 
(1–4) x the number times each indicator received that score.
At the end of Round 1, an initial threshold for continued inclu-
sion was set at or above the median score. Indicators scoring in 
the top half were merged where there was sufficient overlap in 










N N % N N % N N %
Sub- Saharan Africa 4 5 80.0 12 13 92.3 16 18 88.9
South East Asia, East Asia and Oceania 7 9 77.8 4 6 66.7 11 15 73.3
Latin America and Caribbean 6 8 75.0 6 6 100.0 12 14 85.7
South Asia 3 3 100.0 9 10 90.0 12 13 92.3
North Africa and Middle East 1 2 50.0 5 6 83.3 6 8 75.0
High Income 3 3 100.0 3 4 75.0 6 7 85.7
Central Europe, Eastern Europe and Central Asia 2 2 100.0 2 2 100.0 4 4 100.0
‘Global perspective’ 3 3 100.0 2 2 100.0 5 5 100.0
Total 29 35 82.6 43 49 87.8 72 84 85.7
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concepts to do so. Indicators not scoring in the top half were 
reviewed to determine if any concepts deemed essential to score 
in Round 2 had been omitted and should be included to ensure 
representation (online supplemental appendices 2 and 3). In 
total, 95 indicators were forwarded to Round 2.
The prioritisation exercise: round 2
Each of the 95 indicators were scored against four new criteria. 
The panel were asked to indicate their agreement on a 4- point 
Likert scale (1 = ‘strongly disagree’, 2 = ‘disagree’, 3 = ‘agree’, 
4 = ‘strongly agree’) as to whether each indicator was feasible, 
actionable, reliable and internationally comparable (table 2). In 
addition, the panel selected 10 indicators they considered to be 
‘core’ indicators, described as those which all countries could be 
encouraged to adopt. These were ranked 1 (most important) to 
10.
Scores were calculated in the same way as Round 1. Each 
indicator was scored on the criteria separately and a composite 
score of all four was calculated, with all criteria weighted equally. 
Each indicator was assigned a rank position from 1 to 95 for 
each of the four criterion and the overall composite score. The 
ranking of indicators 1 to 10 as core indicators was calculated in 
a similar way: a vote for first place awarded 10 points, second 
place awarded 9 points and so on. Points were multiplied by 
the number of times an indicator received that vote position for 
an overall core score (online supplemental appendices 2 and 3). 
A ranking of 1 to 95 was given based on this scoring and this 
ranking was used in all subsequent analysis. Indicators with the 
same score were ranked equal.
We arrived at a list of 30 priority eye health indicators by 
ranking the Round 2 selections using two metrics:
1. The rank of the indicator based on the core score.
2. The rank of the indicator based on the composite score
We plotted the core and composite scores against each other 
and selected the 30 indicators that scored most highly by both 
ranking methods, by expanding the ‘gating’ equally along both 
axes until the selected area included 30 indicators (online supple-
mental appendices 2 and 3). The selected indicators, therefore, 
scored relatively highly for both.
Development of the indicator menu
Starting with the top 30 indicators from Round 2, we developed 
the detailed indicator menu presented in box 1. In this step we 
aimed to:
 ► Ensure alignment with UHC dimensions of access, quality, 
financial protection and equity
 ► Avoid repetition or misclassification of themes within and 
across domains
 ► Avoid over- representation or under- representation of 
domains
 ► Identify any omissions related to the five most prevalent 
causes of vision impairment globally (cataract, uncorrected 
refractive error, glaucoma, age- related macular degenera-
tion, diabetic retinopathy).14
No major edits to key concepts were undertaken. This process 
is summarised in figure 2.
RESULTS
Twenty- two distinct eye health indicator concepts were identified 
(box 1). In compiling the menu, we articulated broader concepts 
by specifying 39 ‘sub- indicators’ (see bullet points under indi-
cator titles). It is anticipated that these could be used in support 
of defining the broader indicators, for example, whether or 
not eye health is integrated into national health planning. Sub- 
indicators for the concept of eye health financing integration are 
not yet developed and, once included, will increase the scope of 
the menu in this domain.
The steering group selected seven core indicators for moni-
toring eye health as part of countries’ progress towards UHC. 
These are set out in table 3.
DISCUSSION
This process engaged a large panel of global eye health experts 
representing all GBD Super Regions and developed a quantita-
tive approach to prioritise existing indicators. The steering group 
refined the highest ranked selections to produce a menu of indi-
cators for governments to monitor and improve eye health and 
eye health services, aligned with UHC and the Sustainable Devel-
opment Goal on health and in keeping with WHO’s call for such 
a menu in the World Report on Vision. We believe the core indi-
cators highlighted here, if collected by all countries, could allow 
governments, and supranational organisations, to track progress 
on key challenges within eye health and UHC. Otherwise, the 
menu is not intended to be prescriptive; countries could select 
indicators according to priorities based on population need. We 
recognise that some countries will likely benefit from collecting 
and reporting fewer, more important eye health indicators as 
accurately as possible.
The core indicators include two candidate WHO UHC service 
coverage indicators: effective cataract surgical coverage (eCSC) 
and effective refractive error coverage (eREC).15 16 Effective 
coverage has been acknowledged as a useful measure of progress 
towards UHC as it includes dimensions of quality, access and, 
where disaggregated, equity. Both eCSC and eREC were omitted 
from a recent global UHC analysis because of limited data avail-
ability,17 an issue which must be addressed.
The standard UHC financial risk protection indicators (cata-
strophic and impoverishing expenditure) adapted to eye health 
scored lowest among the 95 indicators in Round 2. This likely 
reflects anticipated complexities in data collection and the 
possibility that, for non- emergency healthcare, they may not 
be sufficiently discriminatory. Instead, we have proposed two 
new proxy measures for financial risk protection. These are not 
intended as direct replacements for catastrophic and impover-
ishing expenditure indicators, rather what might be achievable 
within the constraints of eye health data availability. They will 
require additional work to develop a full metadata description 
but provide a way to track eye health insurance coverage (for 
multiple conditions) and out- of- pocket (OOP) payments for 
Table 2 Criteria used to score Round 2 indicators
Criteria Definition
Feasible The indicator can be derived using either available data (eg, routine 
monitoring) or purposeful data collection (eg, population- based 
survey, clinic- based study) without substantial additional resources
Actionable The indicator measures an aspect of eye health within health 
systems that may be used at a national level to create change 
through policymaking or strategy development
Reliable The indicator returns similar results when measuring a stable 




Reporting countries can comply with the relevant data definition; 
any differences in the indicator values between countries reflect 
issues in health systems rather than differences in data collection 
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Box 1 Consolidated indicators menu, integrating global panel indicator preferences with a conceptual framework for 
monitoring eye health as part of universal health coverage.
Equity statement
All indicators summarising population- based and eye care facility- based data should report metrics disaggregated by key 
equitydimensions of sex, place of residence (PoR), socioeconomic position (SEP) and disability status, where available. Additional options, 
suchethnicity or marital status, can be recorded by countries as appropriate.
Inputs and processes
Governance
G1 Eye health is integrated into the national health strategy/plan (or the relevant specific plan, for example, non- communicable diseases)
 ► G1.1 National health plan includes human resources for eye care (Y/N)
 ► G1.2 Eye health is integrated into the plans, policies and budget of other initiatives such as:
  – G1.2.1 National essential package of health services (Y/N)
  – G1.2.2 Primary healthcare (Y/N)
  – G1.2.3 Maternal and child healthcare (Y/N)
  – G1.2.4 Diabetes care (Y/N)
  – G1.2.5 School health programmes (Y/N)
  – G1.2.6 Healthy ageing programmes (Y/N)
 ► G1.3 National eye health policies, plans and programmes refer to a multisectoral approach/engagement with other sectors (Y/N)
  – If a national eye health strategy/ plan is unavailable or not up- to- date, record as N
G2 Is the national eye health plan informed by recent evidence (Y/N):
 ► G2.1 Time since cited population- based data was collected (in months/years)
 ► G2.2 Time since cited Eye Care Service Assessment Tool (ECSAT) data was collected (in months/years)
Finance
F1 Eye health is integrated into the national health budget (Y/N)
 – Requires a working group to develop sub- indicators and metadata
F2 Eye health is included in national health finance pooling mechanism (Y/N)
 – Scaled response based on scoring outcomes of sub- indicators in ‘checklist’
   If yes, the range/number/list of services addressing leading causes of vision impairment (VI) included:
 ► F2.1 Outpatient consultation (Full/Partial/No)
 ► F2.2 Cataract (Full/Partial/No)
 ► F2.3 Refraction services (Full/Partial/No)
 ► F2.4 Glaucoma medication/surgery (Full/Partial/No)
 ► F2.5 Diabetic retinopathy – laser/anti- vascular endothelial growth factor (VEGF) (Full/Partial/No)
F3 Proportion of population covered via national health finance pooling mechanisms that includes eye care services:
 ► F3.1 Proportion covered for: Outpatient consultation
 ► F3.2 Proportion covered for: Cataract
 ► F3.3 Proportion covered for: Refraction services
 ► F3.4 Proportion covered for: Glaucoma medication/surgery
 ► F3.5 Proportion covered for: Diabetic retinopathy – laser/anti- VEGF
Infrastructure
I1 Eye health facility density and distribution, disaggregated by:
 ► I1.1 Primary
 ► I1.2 Secondary
 ► I1.3 Tertiary
 ► I1.4 Low vision services
  – By PoR (urban/rural), total numbers (public and private) per million population
  – Additional subnational administrative or geographical divisions as relevant to setting
 – Additional dimension: Access to primary eye care and cataract surgery via global positioning system data and geospatial modelling
I2 Percentage of neonatal units providing screening for retinopathy of prematurity nationally
Supply chain
SC1 Pharmaceuticals specifically for eye care on the National Essential Medicines List
  – Total number and proportion compared with a normative standard for eye health pharmaceuticals (eg, WHO or International Agency 
for the Prevention of Blindness list)
Information
INFO1 Existence of a National Health Information System that includes eye care service data (Y/N)
Eye health workforce
HR1 Eye health worker density and distribution, disaggregated by:
 ► HR1.1 Ophthalmologist
 ► HR1.2 Optometrist
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treatment of cataract, the most common cause of blindness 
globally. The WHO has acknowledged that monitoring the 
intersection between service coverage and OOP expenditure is 
key to assessing progress towards UHC.18 There may be value 
in expanding this OOP payment indicator to include refractive 
error correction and a pilot test for one or both of these will 
be undertaken in the near future within the Rapid Assessment 
of Avoidable Blindness (RAAB), a well- established population- 
based survey method.19 We acknowledge that relying on OOP 
payment data obscures those people who do not present to care 
due to unaffordable cost, an essential group to identify and reach 
for UHC to be realised.20
Place of residence should not be a barrier to accessing care, 
however, human resources for eye care are skewed towards 
Box 1 Continued
 ► HR1.4 Other allied ophthalmic personnel (as relevant to country)
  – By PoR (urban/rural), total number per million population, and by age groups and sex
  – Additional subnational administrative or geographical divisions as relevant to setting
  – Additional dimension: 5- year trends per cadre
HR2 Is Primary Eye Care integrated into the national Primary Healthcare training (if applicable)? (Y/N)
Outputs
Access
AC1 Cataract surgical rate
 – Total number per million population and including variation in rate across urban/rural or districts
 – Additional dimension: 5- year trend in cataract surgical rate
 – Additional dimension: Surgical case- mix in terms of preoperative visual acuity
Quality and safety
Q1 Cataract surgical outcome (visual acuity)
 – Proportion of eyes with a 'good' outcome (6/18 or better)
 – Proportion of eyes with a ‘poor’ outcome (worse than 6/60)
Q2 Number of priority eye conditions with quality of care/clinical practice guidelines endorsed by relevant regulatory bodies
 ► Q2.1 Cataract (Y/N)
 ► Q2.2 Refractive error (Y/N)
 ► Q2.3 Glaucoma (Y/N)
 ► Q2.4 Age- related macular degeneration (Y/N)
 ► Q2.5 Diabetic retinopathy (Y/N)
 ► Q2.6 Child eye health (Y/N)
Responsiveness/affordability
AF1 Median (range) of out- of- pocket payment made for cataract surgery as a proportion of median monthly household (or individual)
income
 – Report median and mean payment made at point of service (excluding transport, accommodation, sustenance)
 – Disaggregated by provider type (government/public, private for profit, private non- governmental organisation/charity)
 – Additional dimension: proportion reported for poorest vs wealthiest quintiles
Outcomes
Coverage
C1 Cataract surgical coverage and effective cataract surgical coverage
 – CSC (cataract surgical coverage), eCSC (effective CSC), ‘quality gap’ reported, disaggregated by age, sex, SEP, PoR as available
C2 Refractive error coverage and effective refractive error coverage
 – REC (refractive error coverage), eREC (effective REC), ‘quality gap’ reported, disaggregated by age, sex, SEP, PoR as available
C3 Coverage of diabetic retinopathy screening of all people with diabetes (at the frequency recommended in national guidelines)
 – Requires a working group to develop complete indicator metadata
 – Disaggregated by age, sex, SEP, PoR as available
C4 Coverage of school eye health programmes for schools nationally
 – Proportion of schools receiving screening in the past 12 months
 – Disaggregated by primary and secondary schools
Impact
Improved outcomes
P1 Prevalence of VI
 ► P1.1 Distance VI prevalence, by WHO categories
 ► P1.2 Near VI prevalence, by WHO definition
  – From population- based surveys, disaggregated by age, sex, SEP, PoR as available
P2 Cause- specific prevalence of VI
 – Prevalence of vision- impairing priority eye conditions from population- based surveys, disaggregated by age, sex, SEP, PoR as available
 ► P2.1 Avoidable blindness/severe VI/moderate VI/mild VI prevalence disaggregated by age, sex, SEP, PoR as available
 – Aggregated from VI causes assigned in surveys
P3 Prevalence of childhood VI and blindness
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urban settings.21 22 We have included two provider- side measures 
of access: human resources and infrastructure for eye care per 
capita. These can be reported more frequently than service 
coverage estimates and at little cost. The density of eye health 
workers (by cadre) features in all previous eye health indicator 
lists. In order to be UHC- aligned, countries must expand beyond 
aggregate numbers of personnel, and monitor their distribution 
by rural/urban and public/private settings. Disaggregation should 
also be applied to the monitoring of eye care facility density 
and distribution. This metric could be enhanced by geocoding 
infrastructure and integrating geographical coverage with other 
population data to apply a spatial component to eye health 
planning.23
The final concept represented in the core indicators selection 
is the impact of countries’ eye health systems on population 
health in terms of the prevalence of vision impairment. Vision 
impairment affects individuals’ quality of life but is also a broader 
development issue affecting education and employment.24 Vision 
impairment prevalence has been the key measure of eye health 
for decades and continues to be useful at the national level for 
monitoring and planning and at the global level for advocacy.
Beyond the core indicators, key concepts represented in 
the menu include the integration of eye health into national 
health planning and financing. We acknowledge that defining 
and measuring the degree of integration in these areas requires 
further discussion, particularly for health financing. The inte-
gration of primary eye care into primary healthcare planning, 
financing and training programmes is also included, along with 
integration of eye health into HIS.
The importance of data disaggregation to monitor eye care 
equity across the menu should not be understated. We have 
included an equity statement for consideration across the list and 
believe equity- relevant monitoring is essential to ensure the most 
gains are made among population groups with the most need.
Our menu has substantial overlap with WHO’s GAP indi-
cator list, including its six key indicators on vision impairment, 
human resources for eye care and cataract surgical services. 
New concepts in our list include eye care insurance coverage 
and affordability, the UHC dimensions of quality and equity, eye 
health infrastructure and information systems, primary eye care, 
child eye health, refractive error and diabetic retinopathy. Our 
proposed indicators are not only UHC- aligned but also address 
many areas of global eye health prioritised in a recent ‘grand 
challenges’ global Delphi process.12
There are some notable absences from the final menu. The 
concept of ‘people- centred’ eye care proposed in the World 
Report on Vision is not represented. We presented 13 ‘respon-
siveness’ indicators in Round 1, including 7 patient- reported 
outcome indicators, but the panel prioritised none; this will 
require further study. Disease- specific indicators for glaucoma 
and age- related macular degeneration were potentially under- 
represented in the initial long- list and not prioritised by the 
panel, despite their prominence as causes of vision loss globally.14 
This may be because the natural history of these conditions make 
monitoring more complex than for cataract or refractive error. 
Appropriate coverage indicators for these conditions will require 
further investigation, and as the menu evolves, more ‘difficult- 
to- measure’ concepts would ideally be included.12 Trachoma and 
onchocerciasis were not prioritised, likely reflecting the progress 
made in these areas in recent years. However, we expect endemic 
countries would continue to report against indicators aligned 
with their elimination programmes. Unilateral vision impair-
ment, associated with, for example, infectious corneal ulcers, is 
not included in the menu but was identified as a knowledge gap 
in the World Report on Vision and could be included in future 
as it gains priority in eye health planning. The GAP indicator 
for evidence of research on the cost- effectiveness of eye health 
programmes was not prioritised, but more evidence of cost- 
effectiveness may strengthen the case for resource allocation. 
Finally, broader health and financing indicators potentially rele-
vant to eye health (demographics, non- communicable diseases, 
water and sanitation, government health spending) were not 
prioritised but could be obtained from other national reporting 
mechanisms to support eye care planning as appropriate.
We recognise that generating this list is insufficient in isola-
tion, and several challenges must be addressed for these indi-
cators to be successfully integrated into countries’ HIS and 
monitoring frameworks. Fortunately, the priority given to HIS in 
the World Report on Vision and the potential inclusion of eCSC 
and eREC in the next list of WHO UHC indicators provides 
impetus for action. In addition, countries will benefit from the 
ongoing refinement of tools such as WHO’s Eye Care Services 
Assessment Tool25 and RAAB and its Planning Module.19 These 
tools strengthen national HIS capacity by providing guidance 
on data collection and interpretation for a range of indicators 
included in our list. Several of the new indicators proposed here 
require indicator metadata which would ideally be generated by 
subject- specific expert working groups working collaboratively 
with countries. Alongside indicator development, appropriate 
target- setting also requires consultation. Further, there are finan-
cial and logistical challenges for countries to routinely collect 
Figure 2 Flowchart describing the process undertaken to develop the 
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national- level population health data, so rapid surveys of vision 
impairment and eye care services have often been carried out 
at the subnational level to aid local planning. In the absence of 
increased national- level data collection, modelled estimates will 
be required to provide data for global estimates and regional and 
national comparisons with any degree of regularity.
Table 3 Core indicators to monitor universal access to quality, affordable eye care services when needed
Indicator Definition Rationale Data sources
Responsible 
entity Comments
Accessibility of eye health services
Eye health facility density 
and distribution
By place of residence (urban/rural), 
total numbers (public and private) 
of primary, secondary, tertiary and 
low vision services per million 
population
 ► Additional subnational 
administrative or geographical 
divisions as relevant to setting
Place of residence should not 




Health ministry Informs policy and planning about 
location of eye health services in 
relation to population density. 
Outreach programmes may be 
planned according to gaps in 
geographical access to static 
services
Eye health worker 
density and distribution
By place of residence (urban/rural), 
total numbers of ophthalmologist, 
optometrist, ophthalmic nurses and 
other allied ophthalmic personnel 
per million population
 ► Additional subnational 
administrative or geographical 
divisions as relevant to setting
Availability and accessibility 
of eye health workers dictates 
access to care
Facility records, data 
from professional or 
regulatory bodies, 
population data
Health ministry Informs policy and planning on 
recruitment and distribution of 
human resources for eye health.
Known disparities exist in the 
number and distribution of trained 
eye care personnel between 
countries and by urban and rural 
settings within countries
Affordability of eye health services
Coverage of national 
health finance pooling 
mechanisms that include 
eye care services
Proportion of population covered 
with health finance pooling 
mechanisms that include eye care 
services (considered individually):
 ► Outpatient care
 ► Cataract
 ► Refractive error services
 ► Glaucoma treatment
 ► Diabetic retinopathy treatment
Cost should not be a barrier to 
accessing eye care.
Proxy for WHO/World Bank 
UHC financial risk protection 
indicators; catastrophic and/or 
impoverishing OOP payments 
unlikely to be discriminatory 
for monitoring affordability of 
elective eye care services
Health finance 
scheme reports and 
questionnaires
Health ministry Informs policy about eye health 
financing and affordability.
Coverage within the lowest 
wealth quintile should be reported 
alongside the total population to 
monitor equitable coverage of eye 
health financing
OOP payments for 
cataract surgery
Median (and range) of OOP 
payment made for cataract surgery 
as a proportion of median monthly 
household (or individual) income
Cost should not be a barrier to 
accessing eye care.
Proxy for WHO/World Bank 
UHC financial risk protection 
indicators; catastrophic and/or 
impoverishing OOP payments 
unlikely to be discriminatory 
for monitoring affordability of 









Informs policy about eye health 
financing and affordability.
Additional services could be 
monitored in the same way
Effective coverage of cataract and refractive error services
Effective cataract 
surgical coverage
Among the population aged 
50 years and older, people with 
operated cataract and good 
postoperative presenting visual 
acuity as a proportion of all people 
with operated cataract or operable 
cataract
 ► Disaggregated by sex
Sex- disaggregated effective 
coverage measures the UHC 
dimensions of access, quality 
and equity for the leading 









Informs policy and planning about 
the met and unmet need for 
cataract surgical services; candidate 
WHO UHC tracer indicator
Effective refractive error 
coverage
Adults with refractive error 
corrected to a pre- defined visual 
acuity threshold with habitual 
correction as a proportion of 
all people with corrected and 
uncorrected refractive error
 ► Disaggregated by sex
Sex- disaggregated effective 
coverage measures the UHC 
dimensions of access, quality 
and equity for the leading 










Informs policy and planning about 
the met and unmet need for 
refractive error services; candidate 
WHO UHC tracer indicator
Prevalence of vision impairment
Prevalence of VI The prevalence of all cause distance 
and near VI (according to WHO 
definitions)
 ► Disaggregation by key equity 
measures
 ► Disaggregation by avoidable vs 
non- avoidable
Proxy measure of eye health; 
a measure of programmatic 
success in journey towards eye 









Disaggregated VI prevalence 
estimates inform policy makers 
about the impact of eye health 
systems on eye health among 
population subgroups
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We propose that new indicators in this menu be field- tested 
in several contrasting settings, and that the menu be regularly 
reviewed and updated according to user feedback. Such reviews 
would ideally assess whether data collection and indicator usage 
are viable and valuable for both national and subnational plan-
ning, as well as for generating global eye health estimates. These 
steps require ongoing engagement and resourcing to develop 
and maintain the utility of the menu. This may be encouraged by 
a centralised eye health data repository.
Limitations
This study has several limitations. First, inherent in a study that 
recruits experts, the indicators prioritised reflect the preferences 
of those invited to participate. We aimed to be as geographi-
cally representative as possible, however, the North Africa and 
Middle East, High Income and Central Europe, Eastern Europe 
and Central Asia Super Regions had few panellists. Further, 
despite aiming for gender parity, only 40% of the panel were 
women. A more diverse panel may have generated a different 
set of indicators. Second, the online exercise was only available 
in English, however, no nominated panel members were unable 
to participate due to language constraints. Third, personal inter-
ests and familiarity with some concepts over others may have 
led to confirmation bias in scoring by panel members. The 
overlap with existing GAP indicators may be a reflection of this, 
however, the menu does include many new concepts. Finally, 
detailed explanations of new concepts are required which was 
beyond the scope of this prioritisation project.
CONCLUSION
This process sought a broad consensus from 72 eye health 
experts from all world regions to produce a menu of indica-
tors for countries to monitor eye health as part of UHC. From 
a long- list of 200, the final menu consists of 22 indicators that 
represent important concepts in eye health for 2020 and beyond, 
and are relatively feasible, actionable, reliable and internation-
ally comparable. The new direction in global eye health set by 
the World Report on Vision must be supported with investment 
in HIS that include eye health data collection and data moni-
toring via internationally acceptable indicators. We believe this 
list is well- placed to inform the development of new national 
eye health monitoring frameworks and shows where eye health 
metrics might be incorporated into broader UHC monitoring 
indices at national and international levels.
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